Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02115243
What this trial is testing

Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma

Who this might be right for
Unresectable Melanoma
Duke University 4
Testing effectiveness (Phase 2)Looking for participantsNCT06875128
What this trial is testing

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Who this might be right for
Metastatic Breast Cancer in the Liver
Delcath Systems Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00396045
What this trial is testing

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Turin, Italy 54
Testing effectiveness (Phase 2)Study completedNCT00006244
What this trial is testing

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 36
Large-scale testing (Phase 3)Ended earlyNCT03151811
What this trial is testing

Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

Who this might be right for
Multiple Myeloma
Oncopeptides AB 495
Testing effectiveness (Phase 2)Study completedNCT00003353
What this trial is testing

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00305812
What this trial is testing

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 51
Early research (Phase 1)WithdrawnNCT04466475
What this trial is testing

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07481669
What this trial is testing

ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse

Who this might be right for
Lymphoma Patients With High-risk of Central Nervous System Relapse
Second Affiliated Hospital, Zhejiang University, School of Medicine 45
Testing effectiveness (Phase 2)Study completedNCT00307086
What this trial is testing

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03187223
What this trial is testing

Bendamustine and Melphalan in Myeloma

Who this might be right for
Multiple Myeloma
Insel Gruppe AG, University Hospital Bern 120
Testing effectiveness (Phase 2)Study completedNCT00080886
What this trial is testing

Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 68
Testing effectiveness (Phase 2)Study completedNCT00388635
What this trial is testing

Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 60
Early research (Phase 1)Study completedNCT00002750
What this trial is testing

Melphalan in Patients With Neoplastic Meningitis

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more
Duke University 6
Large-scale testing (Phase 3)Study completedNCT00344526
What this trial is testing

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis (AL)
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Study completedNCT01040026
What this trial is testing

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT02919670
What this trial is testing

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 114
Testing effectiveness (Phase 2)Looking for participantsNCT03850366
What this trial is testing

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Who this might be right for
Hematological Malignancy
Henry Ford Health System 15
Not applicableWithdrawnNCT02589860
What this trial is testing

Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant

Who this might be right for
MucositisMultiple MyelomaAmyloidosis+1 more
Sherif S. Farag
Next Page